Ralph A De Fronzo (Ralph DeFronzo, Ralph A DeFronzo)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 56

Top Topics

Combination Therapy

Hypertrophic Cardiomyopathy

Angiotensin Converting Enzyme

Bariatric Surgery

Top Venues

Diabetes, obesity & metabolism

Diabetes spectrum : a publication of the American Diabetes Association

This page only lists publications with an associated author ORCID identifier.

Publications

Neda Rasouli, Naji Younes, Alokananda Ghosh, Jeanine Albu, Robert M Cohen, Ralph A De Fronzo, Elsa Diaz, Laure Sayyed Kassem, José A Luchsinger, Janet B McGill, William I Sivitz, William V Tamborlane, Kristina M Utzschneider, Steven E Kahn, null null
Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial. Diabetes care 47 (4) (2024)
Xi Chen, Devjit Tripathy, Robert Chilton, Andrea Hansis-Diarte, Marzieh Salehi, Carolina Solis-Herrera, Eugenio Cersosimo, Ralph A De Fronzo
Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects. Diabetes 73 (6) (2024)
Siham Abdelgani, Ahmed Khattab, John Adams, Gozde Baskoy, Marissa Brown, Geoff Clarke, Olga Larvenenko, Ralph A De Fronzo, Muhammad A Abdul-Ghani
Empagliflozin Reduces Liver Fat in Individuals With and Without Diabetes. Diabetes care 47 (4) (2024)
Henri Honka, Francesco Rubino, Samantha Pezzica, Richard Peterson, Ralph A De Fronzo, Marzieh Salehi
Differential effect of endogenous glucagon-like peptide-1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery. Diabetes, obesity & metabolism 26 (6) (2024)
Siham Abdelgani, Ahmed Khattab, John Adams, Gozde Baskoy, Marissa Brown, Geoff Clarke, Olga Larvenenko, Ralph A De Fronzo, Muhammad A Abdul-Ghani
Empagliflozin Reduces Liver Fat in Individuals With and Without Diabetes. Diabetes care (2024)
Henri Honka, Francesco Rubino, Samantha Pezzica, Richard Peterson, Ralph A De Fronzo, Marzieh Salehi
Differential effect of endogenous glucagon-like peptide-1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery. Diabetes, obesity & metabolism (2024)
Henri Honka, Francesco Rubino, Samantha Pezzica, Richard Peterson, Ralph A De Fronzo, Marzieh Salehi
Differential effect of endogenous glucagon-like peptide-1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery. Diabetes, obesity & metabolism 26 (6) (2024)
Neda Rasouli, Naji Younes, Alokananda Ghosh, Jeanine Albu, Robert M Cohen, Ralph A De Fronzo, Elsa Diaz, Laure Sayyed Kassem, José A Luchsinger, Janet B McGill, William I Sivitz, William V Tamborlane, Kristina M Utzschneider, Steven E Kahn, null null
Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial. Diabetes care 47 (4) (2024)
Neda Rasouli, Naji Younes, Alokananda Ghosh, Jeanine Albu, Robert M Cohen, Ralph A De Fronzo, Elsa Diaz, Laure Sayyed Kassem, José A Luchsinger, Janet B McGill, William I Sivitz, William V Tamborlane, Kristina M Utzschneider, Steven E Kahn, null null
Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial. Diabetes care 47 (4) (2024)
Henri Honka, Francesco Rubino, Samantha Pezzica, Richard Peterson, Ralph A De Fronzo, Marzieh Salehi
Differential effect of endogenous glucagon-like peptide-1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery. Diabetes, obesity & metabolism 26 (6) (2024)
Siham Abdelgani, Ahmed Khattab, John Adams, Gozde Baskoy, Marissa Brown, Geoff Clarke, Olga Larvenenko, Ralph A De Fronzo, Muhammad A Abdul-Ghani
Empagliflozin Reduces Liver Fat in Individuals With and Without Diabetes. Diabetes care 47 (4) (2024)
Xi Chen, Devjit Tripathy, Robert Chilton, Andrea Hansis-Diarte, Marzieh Salehi, Carolina Solis-Herrera, Eugenio Cersosimo, Ralph A De Fronzo
Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects. Diabetes 73 (6) (2024)
Neda Rasouli, Naji Younes, Alokananda Ghosh, Jeanine Albu, Robert M Cohen, Ralph A De Fronzo, Elsa Diaz, Laure Sayyed Kassem, José A Luchsinger, Janet B McGill, William I Sivitz, William V Tamborlane, Kristina M Utzschneider, Steven E Kahn, null null
Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial. Diabetes care 47 (4) (2024)
Xi Chen, Devjit Tripathy, Robert Chilton, Andrea Hansis-Diarte, Marzieh Salehi, Carolina Solis-Herrera, Eugenio Cersosimo, Ralph A De Fronzo
Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects. Diabetes 73 (6) (2024)
Kristina M Utzschneider, Naji Younes, Nicole M Butera, Ashok Balasubramanyam, Richard M Bergenstal, Joshua I Barzilay, Cyrus V Desouza, Ralph A De Fronzo, Tom Elasy, Jonathan Krakoff, Steven E Kahn, Neda Rasouli, Willy M Valencia, William I Sivitz, null null
Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): Differential Treatment Effects of Dual Therapy. Diabetes care 47 (4) (2024)
Kristina M Utzschneider, Naji Younes, Nicole M Butera, Ashok Balasubramanyam, Richard M Bergenstal, Joshua I Barzilay, Cyrus V Desouza, Ralph A De Fronzo, Tom Elasy, Jonathan Krakoff, Steven E Kahn, Neda Rasouli, Willy M Valencia, William I Sivitz, null null
Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): Differential Treatment Effects of Dual Therapy. Diabetes care 47 (4) (2024)
Kristina M Utzschneider, Naji Younes, Nicole M Butera, Ashok Balasubramanyam, Richard M Bergenstal, Joshua I Barzilay, Cyrus V Desouza, Ralph A De Fronzo, Tom Elasy, Jonathan Krakoff, Steven E Kahn, Neda Rasouli, Willy M Valencia, William I Sivitz, null null
Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study): Differential Treatment Effects of Dual Therapy. Diabetes care (2024)
Neda Rasouli, Naji Younes, Alokananda Ghosh, Jeanine Albu, Robert M Cohen, Ralph A De Fronzo, Elsa Diaz, Laure Sayyed Kassem, José A Luchsinger, Janet B McGill, William I Sivitz, William V Tamborlane, Kristina M Utzschneider, Steven E Kahn, null null
Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial. Diabetes care (2024)
Henri Honka, Francesco Rubino, Samantha Pezzica, Richard Peterson, Ralph A De Fronzo, Marzieh Salehi
Differential effect of endogenous glucagon-like peptide-1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery. Diabetes, obesity & metabolism 26 (6) (2024)
Xi Chen, Devjit Tripathy, Robert Chilton, Andrea Hansis-Diarte, Marzieh Salehi, Carolina Solis-Herrera, Eugenio Cersosimo, Ralph A De Fronzo
Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects. Diabetes 73 (6) (2024)
Neda Rasouli, Naji Younes, Alokananda Ghosh, Jeanine Albu, Robert M Cohen, Ralph A De Fronzo, Elsa Diaz, Laure Sayyed Kassem, José A Luchsinger, Janet B McGill, William I Sivitz, William V Tamborlane, Kristina M Utzschneider, Steven E Kahn, null null
Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial. Diabetes care 47 (4) (2024)
Siham Abdelgani, Ahmed Khattab, John Adams, Gozde Baskoy, Marissa Brown, Geoff Clarke, Olga Larvenenko, Ralph A De Fronzo, Muhammad A Abdul-Ghani
Empagliflozin Reduces Liver Fat in Individuals With and Without Diabetes. Diabetes care 47 (4) (2024)
Kristina M Utzschneider, Naji Younes, Nicole M Butera, Ashok Balasubramanyam, Richard M Bergenstal, Joshua I Barzilay, Cyrus V Desouza, Ralph A De Fronzo, Tom Elasy, Jonathan Krakoff, Steven E Kahn, Neda Rasouli, Willy M Valencia, William I Sivitz, null null
Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): Differential Treatment Effects of Dual Therapy. Diabetes care 47 (4) (2024)
Kristina M Utzschneider, Naji Younes, Nicole M Butera, Ashok Balasubramanyam, Richard M Bergenstal, Joshua I Barzilay, Cyrus V Desouza, Ralph A De Fronzo, Tom Elasy, Jonathan Krakoff, Steven E Kahn, Neda Rasouli, Willy M Valencia, William I Sivitz, null null
Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study): Differential Treatment Effects of Dual Therapy. Diabetes care (2024)
Kristina M Utzschneider, Naji Younes, Nicole M Butera, Ashok Balasubramanyam, Richard M Bergenstal, Joshua I Barzilay, Cyrus V Desouza, Ralph A De Fronzo, Tom Elasy, Jonathan Krakoff, Steven E Kahn, Neda Rasouli, Willy M Valencia, William I Sivitz, null null
Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): Differential Treatment Effects of Dual Therapy. Diabetes care 47 (4) (2024)
Siham Abdelgani, Ahmed Khattab, John Adams, Gozde Baskoy, Marissa Brown, Geoff Clarke, Olga Larvenenko, Ralph A De Fronzo, Muhammad A Abdul-Ghani
Empagliflozin Reduces Liver Fat in Individuals With and Without Diabetes. Diabetes care 47 (4) (2024)
John Armato, Ralph A De Fronzo, Muhammad Abdul-Ghani, Ron Ruby
Pre-Prediabetes: Insulin Resistance is Associated with Cardiometabolic Risk in Non-obese Patients (STOP DIABETES). The Journal of clinical endocrinology and metabolism (2024)
Neda Rasouli, Naji Younes, Alokananda Ghosh, Jeanine Albu, Robert M Cohen, Ralph A De Fronzo, Elsa Diaz, Laure Sayyed Kassem, José A Luchsinger, Janet B McGill, William I Sivitz, William V Tamborlane, Kristina M Utzschneider, Steven E Kahn, null null
Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial. Diabetes care (2024)
Henri Honka, Francesco Rubino, Samantha Pezzica, Richard Peterson, Ralph A De Fronzo, Marzieh Salehi
Differential effect of endogenous glucagon-like peptide-1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery. Diabetes, obesity & metabolism (2024)
Neda Rasouli, Naji Younes, Alokananda Ghosh, Jeanine Albu, Robert M Cohen, Ralph A De Fronzo, Elsa Diaz, Laure Sayyed Kassem, José A Luchsinger, Janet B McGill, William I Sivitz, William V Tamborlane, Kristina M Utzschneider, Steven E Kahn, null null
Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial. Diabetes care (2024)
Neda Rasouli, Naji Younes, Alokananda Ghosh, Jeanine Albu, Robert M Cohen, Ralph A De Fronzo, Elsa Diaz, Laure Sayyed Kassem, José A Luchsinger, Janet B McGill, William I Sivitz, William V Tamborlane, Kristina M Utzschneider, Steven E Kahn, null null
Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial. Diabetes care 47 (4) (2024)
Kristina M Utzschneider, Naji Younes, Nicole M Butera, Ashok Balasubramanyam, Richard M Bergenstal, Joshua I Barzilay, Cyrus V Desouza, Ralph A De Fronzo, Tom Elasy, Jonathan Krakoff, Steven E Kahn, Neda Rasouli, Willy M Valencia, William I Sivitz, null null
Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): Differential Treatment Effects of Dual Therapy. Diabetes care 47 (4) (2024)
Mariam Alatrach, Christina Agyin, Carolina Solis-Herrera, Olga Lavryneko, John Adams, Amalia Gastaldelli, Curtis Triplitt, Ralph A De Fronzo, Eugenio Cersosimo
Dapagliflozin Impairs the Suppression of Endogenous Glucose Production in Type 2 Diabetes Following Oral Glucose. Diabetes care 45 (6) (2022)
Jiyoon Ryu, Jason T Hadley, Zhi Li, Feng Dong, Huan Xu, Xiaoban Xin, Ye Zhang, Cang Chen, Senlin Li, Xiaoning Guo, Jared L Zhao, Robin J Leach, Muhammad A Abdul-Ghani, Ralph A De Fronzo, Amrita Kamat, Feng Liu, Lily Q Dong
Adiponectin Alleviates Diet-Induced Inflammation in the Liver by Suppressing MCP-1 Expression and Macrophage Infiltration. Diabetes 70 (6) (2021)
Francesco Rubino, Ralph A De Fronzo, Marzieh Salehi
Comment on Piccinini and Bergman. The Measurement of Insulin Clearance. Diabetes Care 2020;43:2296-2302. Diabetes care 44 (5) (2021)
Ralph A De Fronzo, Muhammad A Abdul-Ghani
Sodium-Glucose Cotransporter 2 Inhibitors and the Kidney. Diabetes spectrum : a publication of the American Diabetes Association 34 (3) (2021)
Nitchakarn Laichuthai, Muhammad Abdul-Ghani, Mikhail Naum Kosiborod, Wasita Warachit Parksook, Stephen J Kerr, Ralph A De Fronzo
Newly Discovered Abnormal Glucose Tolerance in Patients With Acute Myocardial Infarction and Cardiovascular Outcomes: A Meta-analysis. Diabetes care 43 (8) (2021)
Vasudha Ahuja, Pasi Aronen, T A Pramodkumar, Helen Looker, Angela Chetrit, Aini H Bloigu, Auni Juutilainen, Cristina Bianchi, Lucia La Sala, Ranjit Mohan Anjana, Rajendra Pradeepa, Ulagamadesan Venkatesan, Sarvanan Jebarani, Viswanathan Baskar, Teresa Vanessa Fiorentino, Patrick Timpel, Ralph A De Fronzo, Antonio Ceriello, Stephano Del Prato, Muhammad A Abdul-Ghani, Sirkka Keinänen-Kiukaanniemi, Rachel Dankner, Peter H Bennett, William C Knowler, Peter Schwarz, Giorgio Sesti, Rie Oka, Viswanathan Mohan, Leif Groop, Jaakko Tuomilehto, Samuli Ripatti, Michael Bergman, Tiinamaija Tuomi
Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis. Diabetes care 44 (4) (2021)
Ralph A De Fronzo, Guest Editor
Preface: Cardiorenal Considerations for Type 2 Diabetes-Time to Exit the Dark Ages. Diabetes spectrum : a publication of the American Diabetes Association 34 (3) (2021)
Roberto Bizzotto, Domenico Tricò, Andrea Natali, Francesco Rubino, Elza Muscelli, Ralph A De Fronzo, Silva A Arslanian, Eleuterio Ferrannini, Andrea Mari
New Insights on the Interactions Between Insulin Clearance and the Main Glucose Homeostasis Mechanisms. Diabetes care 44 (9) (2021)
Neda Rasouli, Naji Younes, Kristina M Utzschneider, Catherine M Viscoli, Ashok Balasubramanyam, Andrea L Cherrington, Faramarz Ismail-Beigi, Robert M Cohen, Darin E Olson, Ralph A De Fronzo, William H Herman, John M Lachin, Steven E Kahn, null null
Association of Baseline Characteristics With Insulin Sensitivity and β-Cell Function in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study Cohort. Diabetes care 44 (2) (2020)
Carolina Solis-Herrera, Giuseppe Daniele, Mariam Alatrach, Christina Agyin, Curtis Triplitt, John Adams, Rupal Patel, Francesco Rubino, Henri Honka, Xi Chen, Muhammad Abdul-Ghani, Eugenio Cersosimo, Stephano Del Prato, Ralph A De Fronzo
Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion. Diabetes care 43 (5) (2020)
Yuejuan Qin, John Adams, Carolina Solis-Herrera, Curtis Triplitt, Ralph A De Fronzo, Eugenio Cersosimo
Clinical Parameters, Fuel Oxidation, and Glucose Kinetics in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin. Diabetes care 43 (10) (2020)
Aurora Merovci, Devjit Tripathy, Xi Chen, Ivan Valdez, Muhammad A Abdul-Ghani, Carolina Solis-Herrera, Francesco Rubino, Ralph A De Fronzo
Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance, and Insulin Sensitivity in Healthy Glucose-Tolerant Subjects. Diabetes 70 (1) (2020)
Ali Muhammed Ali, Robert Martinez, Hussein Al-Jobori, John Adams, Curtis Triplitt, Ralph A De Fronzo, Eugenio Cersosimo, Muhammad Abdul-Ghani
Combination Therapy With Canagliflozin Plus Liraglutide Exerts Additive Effect on Weight Loss, but Not on HbA1c, in Patients With Type 2 Diabetes. Diabetes care 43 (6) (2020)
Mariam Alatrach, Nitchakarn Laichuthai, Robert Martinez, Christina Agyin, Ali Muhammed Ali, Hussein Al-Jobori, Olga Lavynenko, John Adams, Curtis Triplitt, Ralph A De Fronzo, Eugenio Cersosimo, Muhammad Abdul-Ghani
Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors. Diabetes 69 (4) (2020)
Muhammad A Abdul-Ghani, Curtiss Puckett, John Adams, Ahmad Khattab, Gozde Baskoy, Eugenio Cersosimo, Curtis Triplitt, Ralph A De Fronzo
Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT. Diabetes care 44 (2) (2020)
Francesco Rubino, Muhammad A Abdul-Ghani, Ralph A De Fronzo
Adaptation of Insulin Clearance to Metabolic Demand Is a Key Determinant of Glucose Tolerance. Diabetes 70 (2) (2020)
Muhammad Abdul-Ghani, Ralph A De Fronzo
Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes Algorithm. Diabetes care 40 (8) (2018)
Christopher E Shannon, Aurora Merovci, Juan Xiong, Devjit Tripathy, Felipe Lorenzo, Donald McClain, Muhammad Abdul-Ghani, Luke Norton, Ralph A De Fronzo
Effect of Chronic Hyperglycemia on Glucose Metabolism in Subjects With Normal Glucose Tolerance. Diabetes 67 (12) (2018)
Robert Martinez, Hussein Al-Jobori, Ali M Ali, John Adams, Muhammad Abdul-Ghani, Curtis Triplitt, Ralph A De Fronzo, Eugenio Cersosimo
Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy. Diabetes 67 (6) (2018)
Muhammad Abdul-Ghani, Ralph A De Fronzo, Stefano Del Prato, Robert Chilton, Rajvir Singh, Robert E J Ryder
Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived? Diabetes care 40 (7) (2017)
Josep M Mercader, Rachel G Liao, Avery D Bell, Zachary Dymek, Karol Estrada, Taru Tukiainen, Alicia Huerta-Chagoya, Hortensia Moreno-Macías, Kathleen A Jablonski, Robert L Hanson, Geoffrey A Walford, Ignasi Moran, Ling Chen, Vineeta Agarwala, María Luisa Ordoñez-Sánchez, Rosario Rodríguez-Guillen, Maribel Rodríguez-Torres, Yayoi Segura-Kato, Humberto García-Ortiz, Federico Centeno-Cruz, Francisco Barajas-Olmos, Lizz Caulkins, Sobha Puppala, Pierre Fontanillas, Amy L Williams, Sílvia Bonàs-Guarch, Chris Hartl, Stephan Ripke, null null, Katherine Tooley, Jacqueline Lane, Carlos Zerrweck, Angélica Martínez-Hernández, Emilio J Córdova, Elvia Mendoza-Caamal, Cecilia Contreras-Cubas, María E González-Villalpando, Ivette Cruz-Bautista, Liliana Muñoz-Hernández, Donaji Gómez-Velasco, Ulises Alvirde, Brian E Henderson, Lynne R Wilkens, Loic Le Marchand, Olimpia Arellano-Campos, Laura Riba, Maegan Harden, null null, Stacey Gabriel, null null, Hanna E Abboud, Maria L Cortes, Cristina Revilla-Monsalve, Sergio Islas-Andrade, Xavier Soberon, Joanne E Curran, Christopher P Jenkinson, Ralph A De Fronzo, Donna M Lehman, Craig L Hanis, Graeme I Bell, Michael Boehnke, John Blangero, Ravindranath Duggirala, Richa Saxena, Daniel MacArthur, Jorge Ferrer, Steven A McCarroll, David Torrents, William C Knowler, Leslie J Baier, Noel Burtt, Clicerio González-Villalpando, Christopher A Haiman, Carlos A Aguilar-Salinas, Teresa Tusié-Luna, Jason Flannick, Suzanne B R Jacobs, Lorena Orozco, David Altshuler, Jose C Florez, null null
A Loss-of-Function Splice Acceptor Variant in IGF2 Is Protective for Type 2 Diabetes. Diabetes 66 (11) (2017)
Geoffrey D Clarke, Carolina Solis-Herrera, Marjorie Molina-Wilkins, Sandra Martinez, Aurora Merovci, Eugenio Cersosimo, Robert J Chilton, Patricia Iozzo, Francesco Rubino, Muhammad Abdul-Ghani, Ralph A De Fronzo
Pioglitazone Improves Left Ventricular Diastolic Function in Subjects With Diabetes. Diabetes care 40 (11) (2017)
Hussein Al-Jobori, Giuseppe Daniele, Eugenio Cersosimo, Curtis Triplitt, Rucha Mehta, Luke Norton, Ralph A De Fronzo, Muhammad Abdul-Ghani
Empagliflozin and Kinetics of Renal Glucose Transport in Healthy Individuals and Individuals With Type 2 Diabetes. Diabetes 66 (7) (2017)
Muhammad Abdul-Ghani, Hussein Al Jobori, Giuseppe Daniele, John Adams, Eugenio Cersosimo, Curtis Triplitt, Ralph A De Fronzo
Inhibition of Renal Sodium-Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose. Diabetes 66 (9) (2017)